U.S. Female External Catheter Market (By Material: Silicone, Latex; By Application: Diabetes, Strokes; By Area of Incontinence; By End-use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

U.S. Female External Catheter Market Size and Growth

The U.S. female external catheter market size was estimated at USD 347.95 million in 2023 and it is expected to surpass around USD 582.07 million by 2033, poised to grow at a CAGR of 5.28% from 2024 to 2033.

U.S. Female External Catheter Market Size 2024 to 2033

Key Pointers

  • By Material, the silicone segment registered the maximum market share in 2023.
  • By Material, the latex segment is estimated to expand the fastest CAGR of 5.61% from 2024 to 2033.
  • By Application, the diabetes segment registered the maximum market share in 2023.
  • By Area of Incontinence, the Stress Urinary Incontinence (SUI) was the dominant segment in 2023.
  • By End-use, the hospitals contributed the largest market share in 2023.
  • By End-use, the home care segment is anticipated to grow at the noteworthy CAGR of of 7.43% from 2024 to 2033.

U.S. Female External Catheter Market Overview

The U.S. female external catheter market is experiencing significant growth due to increasing awareness of female health issues, advancements in medical technology, and the rising prevalence of urinary incontinence among women. Female external catheters are non-invasive devices designed to manage urinary incontinence, offering a comfortable and hygienic alternative to traditional methods such as adult diapers and internal catheters.

U.S. Female External Catheter Market Growth Factors

The growth of the U.S. female external catheter market is driven by the rising prevalence of urinary incontinence among women, particularly due to aging, pregnancy, childbirth, and menopause, significantly boosts demand. Technological advancements have also played a crucial role, with innovations leading to more comfortable, efficient, and user-friendly catheters. Increased awareness and acceptance of urinary incontinence solutions among women and healthcare providers further propel market growth. Additionally, the growing geriatric population in the U.S. amplifies the need for effective incontinence management products.

What are the Trends in U.S. Female External Catheter Market?

  • Home Care Adoption: There is a growing trend toward managing urinary incontinence at home rather than in healthcare facilities. This shift is driven by patient preference for privacy and convenience, as well as the rise of telehealth services.
  • Rising Awareness Campaigns: Greater efforts to raise awareness about urinary incontinence and available treatment options are contributing to increased acceptance and usage of female external catheters. Educational initiatives aim to reduce stigma and encourage more women to seek appropriate care.
  • Focus on Patient Comfort: Manufacturers are prioritizing patient comfort and ease of use in their product designs. Features such as skin-friendly adhesives and easy-to-apply systems are becoming standard to enhance user experience.
  • E-commerce Growth: The increasing popularity of online shopping is influencing the market, with more consumers purchasing female external catheters through e-commerce platforms. This trend is driven by the convenience of online purchasing and the availability of a wide range of products.
  • Customization and Personalization: There is a growing trend towards personalized solutions, with products designed to meet the specific needs of individual patients. Customization options are improving the fit and effectiveness of external catheters.

What are the Key Challenges Faced by U.S. Female External Catheter Market?

  • Product Awareness and Training: There is a lack of widespread awareness and proper training among healthcare providers and patients regarding the use of female external catheters. This can lead to underutilization and improper use of the products.
  • Discomfort and Skin Issues: Some patients may experience discomfort or skin irritation from external catheters. Despite advances in design, ensuring optimal skin compatibility and comfort remains a challenge.
  • Market Fragmentation: The market is fragmented with numerous players offering varying products, which can lead to confusion and difficulty for consumers in selecting the most suitable option.
  • Regulatory Hurdles: Navigating regulatory requirements and obtaining approvals for new and innovative catheter designs can be complex and time-consuming, potentially delaying market entry and innovation.

Material Insights

In 2023, the silicone segment led the market, primarily due to the exceptional comfort and durability offered by silicone-based catheters. The smooth, soft surface of silicone minimizes irritation and discomfort, while its robustness ensures a longer catheter lifespan and reduces the need for frequent replacements. The popularity of silicone-based female external catheters in the U.S. can be attributed to their superior performance and patient benefits. With increasing patient awareness regarding bladder health and catheter care, silicone-based catheters are expected to remain the top choice for those seeking comfort, durability, and ease of use.

Conversely, the latex segment is anticipated to experience the highest growth rate, with a CAGR of 5.61% during the forecast period. Although silicone-based catheters have traditionally dominated the market, some patients prefer latex-based options due to concerns about silicone allergies or sensitivities. Additionally, FDA regulations concerning latex-containing medical devices have contributed to the rising adoption of latex-based catheters as a safer alternative.

Application Insights

In 2023, the diabetes segment was the leading market driver due to the increasing prevalence of diabetes-related incontinence and advancements in related technology. To stay competitive, companies must focus on developing innovative products that address compliance and cost challenges while leveraging digital health solutions to enhance patient outcomes. Investments in research and development are also crucial to creating more comfortable, convenient, and effective catheters for patients with diabetes-related incontinence.

This segment is projected to achieve the highest CAGR of 5.98% during the forecast period, driven by the steady rise in diabetes prevalence. According to the Centers for Disease Control and Prevention (CDC), diabetes rates rose by 6% between 2021 and 2022, from 10.9% to 11.5% of adults, affecting nearly 31.9 million individuals.

Area of Incontinence Insights

In 2023, Stress Urinary Incontinence (SUI) was the dominant segment. This dominance is attributed to increased awareness of urinary incontinence and its effects on both mental and physical health. Contributing factors include the growing geriatric population, rising obesity rates, and sedentary lifestyles. Technological advancements have also led to the development of innovative products tailored to the needs of women suffering from SUI.

Data from a comprehensive analysis covering 2015-2018, published in the American Urogynecologic Society's official journal, reveals that 61.8% of adult women in the U.S. experience urinary incontinence (UI), translating to approximately 78.3 million women. Additionally, 32.4% of women reported UI symptoms at least once a month. Among those with UI, the distribution is as follows: 37.5% with stress urinary incontinence, 22.0% with urgency urinary incontinence, 31.3% with mixed symptoms, and 9.2% with unspecified incontinence.

End-use Insights

Hospitals were the leading end-use segment in 2023, driven by high patient volumes, the growing prevalence of urinary incontinence, and government initiatives promoting evidence-based treatments. As the market evolves, companies must focus on innovation, digital health solutions, and patient engagement to maintain competitiveness and capitalize on growth opportunities.

The home care segment is expected to grow at the highest rate, with a CAGR of 7.43% during the forecast period, driven by increasing demand for convenience, comfort, and cost-effective solutions. To stay competitive, companies must emphasize innovation, digital health solutions, and patient education. Key players in the home care segment, such as BD and Consure Medical, are investing in research and development to stay ahead and capitalize on emerging market opportunities.

Who are the Top Manufactures in U.S. Female External Catheter Market?

  • BD
  • Stryker
  • Boehringer Laboratories, LLC.
  • Consure Medical
  • Hollister Incorporated
  • Huons Global

U.S. Female External Catheter Market Segmentation:

By Material

  • Silicone
  • Latex

By Application

  • Diabetes
  • Strokes
  • Alzheimer's disease
  • Parkinson's disease
  • Spinal Cord Injury
  • Bladder Cancer
  • Ovarian Cancer
  • Multiple Sclerosis
  • Others

By Area of Incontinence

  • Stress Urinary Incontinence
  • Urge/OAB (Overactive Bladder)
  • Overflow
  • Functional
  • Mixed
  • Reflex
  • Severe Incontinence

By End-use

  • Home Care
  • Hospitals
  • Other End-use

Frequently Asked Questions

The U.S. female external catheter market size was reached at USD 347.95 million in 2023 and it is projected to hit around USD 347.95 million by 2033.

The U.S. female external catheter market is growing at a compound annual growth rate (CAGR) of 5.28% from 2024 to 2033.

The leading companies operating in the U.S. female external catheter market are BD, Stryker, Boehringer Laboratories, LLC., Consure Medical and Hollister Incorporated.

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers